The <i>RCAN1.4</i> Metastasis Suppressor Is Hypermethylated at Intron 1 in Thyroid Cancer-Reference-Cited by-同舟云学术

The RCAN1.4 Metastasis Suppressor Is Hypermethylated at Intron 1 in Thyroid Cancer

Published:2023-08-01 Issue:8 Volume:33 Page:965-973
ISSN:1050-7256
Container-title:Thyroid®
language:en
Short-container-title:Thyroid®

Author:

Khanal Tilak¹,Rajan Neel¹,Li Wei¹,Liyanarachchi Sandya¹,Ringel Matthew D.¹

Affiliation:

1. Division of Endocrinology, Diabetes, and Metabolism, Departments of Internal Medicine and Molecular Medicine and Therapeutics, The Ohio State University College of Medicine and Comprehensive Cancer Center, Columbus, Ohio, USA.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2022.0687

Reference55 articles.

1. Thyroid Cancer Incidence Trends in the United States: Association with Changes in Professional Guideline Recommendations

2. Progression and dormancy in metastatic thyroid cancer: concepts and clinical implications

3. Adverse Histological Features of Differentiated Thyroid Cancer Are Commonly Found in Autopsy Studies: Implications for Treatment Guidelines

4. Divergent Metastatic Patterns Between Subtypes of Thyroid Carcinoma Results From the Nationwide Dutch Pathology Registry

5. Metastasis Suppressor Genes

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New insight into the CNC-bZIP member, NFE2L3, in human diseases;Frontiers in Cell and Developmental Biology;2024-07-23

2. Research Progress on the Role of Epigenetic Methylation Modification in Hepatocellular Carcinoma;Journal of Hepatocellular Carcinoma;2024-06